| Year |
Citation |
Score |
| 2020 |
Mátyási B, Farkas Z, Kopper L, Sebestyén A, Boissan M, Mehta A, Takács-Vellai K. The Function of NM23-H1/NME1 and Its Homologs in Major Processes Linked to Metastasis. Pathology Oncology Research : Por. PMID 31993913 DOI: 10.1007/S12253-020-00797-0 |
0.35 |
|
| 2018 |
Sticz T, Molnár A, Dankó T, Hujber Z, Petővári G, Nagy N, Végső G, Kopper L, Sebestyén A. The Effects of Different mTOR Inhibitors in EGFR Inhibitor Resistant Colon Carcinoma Cells. Pathology Oncology Research : Por. PMID 29882195 DOI: 10.1007/S12253-018-0434-4 |
0.395 |
|
| 2016 |
Sticz T, Molnár A, Márk Á, Hajdu M, Nagy N, Végső G, Micsik T, Kopper L, Sebestyén A. mTOR activity and its prognostic significance in human colorectal carcinoma depending on C1 and C2 complex-related protein expression. Journal of Clinical Pathology. PMID 27729429 DOI: 10.1136/Jclinpath-2016-203913 |
0.318 |
|
| 2015 |
Sebestyén A, Márk Á, Hajdu M, Nagy N, Molnár A, Végs? G, Barna G, Kopper L. Rapamycin can restore the negative regulatory function of transforming growth factor beta 1 in high grade lymphomas. Cytokine. 73: 219-24. PMID 25794661 DOI: 10.1016/J.Cyto.2015.02.024 |
0.654 |
|
| 2015 |
Sebestyén A, Nagy N, Márk Á, Molnár A, Dankó T, Hajdu M, Tóth M, Timár B, Csóka M, Kopper L. Abstract B47: mTOR C1/2 activities - related protein expression and its potential prognostic/therapeutic importance in certain lymphoid malignancies Molecular Cancer Therapeutics. 14. DOI: 10.1158/1538-8514.Pi3K14-B47 |
0.436 |
|
| 2014 |
Schwab R, Petak I, Kollar M, Pinter F, Varkondi E, Kohanka A, Barti-Juhasz H, Schönleber J, Brauswetter D, Kopper L, Urban L. Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement. Lung Cancer (Amsterdam, Netherlands). 83: 109-11. PMID 24192513 DOI: 10.1016/J.Lungcan.2013.10.006 |
0.33 |
|
| 2013 |
Márk Ã, Hajdu M, Váradi Z, Sticz TB, Nagy N, Csomor J, Berczi L, Varga V, Csóka M, Kopper L, Sebestyén A. Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease--a combined tissue microarray, in vitro and in vivo study. Bmc Cancer. 13: 250. PMID 23693095 DOI: 10.1186/1471-2407-13-250 |
0.441 |
|
| 2013 |
Nemes K, Sebestyén A, Márk A, Hajdu M, Kenessey I, Sticz T, Nagy E, Barna G, Váradi Z, Kovács G, Kopper L, Csóka M. Mammalian target of rapamycin (mTOR) activity dependent phospho-protein expression in childhood acute lymphoblastic leukemia (ALL). Plos One. 8: e59335. PMID 23573198 DOI: 10.1371/Journal.Pone.0059335 |
0.638 |
|
| 2012 |
Sebestyén A, Sticz TB, Márk A, Hajdu M, Timár B, Nemes K, Nagy N, Váradi Z, Kopper L. Activity and complexes of mTOR in diffuse large B-cell lymphomas--a tissue microarray study. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 25: 1623-8. PMID 22899290 DOI: 10.1038/Modpathol.2012.141 |
0.401 |
|
| 2012 |
Kopper L, Sebestyén A, Gallai M, Kovalszky I. Syndecan-1 - A new piece in B-cell puzzle. Pathology Oncology Research : Por. 3: 183-91. PMID 18470728 DOI: 10.1007/Bf02899919 |
0.403 |
|
| 2012 |
Mark A, Hajdu M, Sticz T, Varadi Z, Nagy N, Timar B, Csoka M, Kopper L, Sebestyen A. 798 Mammalian Target of Rapamycin (mTOR) Activity as a Potential Target in Human Diffuse Large B-cell Lymphomas and Hodgkin Lymphomas European Journal of Cancer. 48: S190. DOI: 10.1016/S0959-8049(12)71431-4 |
0.352 |
|
| 2011 |
Balla P, Moskovszky L, Sapi Z, Forsyth R, Knowles H, Athanasou NA, Szendroi M, Kopper L, Rajnai H, Pinter F, Petak I, Benassi MS, Picci P, Conti A, Krenacs T. Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone. Histopathology. 59: 376-89. PMID 22034878 DOI: 10.1111/J.1365-2559.2011.03948.X |
0.31 |
|
| 2011 |
Egervári G, Márk A, Hajdu M, Barna G, Sápi Z, Krenács T, Kopper L, Sebestyén A. Mitotic lymphoma cells are characterized by high expression of phosphorylated ribosomal S6 protein. Histochemistry and Cell Biology. 135: 409-17. PMID 21424608 DOI: 10.1007/S00418-011-0803-5 |
0.676 |
|
| 2011 |
Sticz TB, Mark A, Hajdu M, Timar B, Nemes K, Kopper L, Sebestyen A. Abstract 3163: Tissue-micro array based IHC analysis of mTOR activity in DLBCL Cancer Research. 71: 3163-3163. DOI: 10.1158/1538-7445.Am2011-3163 |
0.386 |
|
| 2010 |
Moskovszky L, Dezsö K, Athanasou N, Szendröi M, Kopper L, Kliskey K, Picci P, Sápi Z. Centrosome abnormalities in giant cell tumour of bone: possible association with chromosomal instability. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 23: 359-66. PMID 20062006 DOI: 10.1038/Modpathol.2009.134 |
0.306 |
|
| 2010 |
Hajdu M, Kopper L, Sebestyén A. Notch-regulation upon Dll4-stimulation of TGFb-induced apoptosis and gene expression in human B-cell non-Hodgkin lymphomas. Scandinavian Journal of Immunology. 71: 29-37. PMID 20017807 DOI: 10.1111/J.1365-3083.2009.02346.X |
0.5 |
|
| 2009 |
Moskovszky L, Szuhai K, Krenács T, Hogendoorn PC, Szendroi M, Benassi MS, Kopper L, Füle T, Sápi Z. Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis. Genes, Chromosomes & Cancer. 48: 468-79. PMID 19242928 DOI: 10.1002/Gcc.20656 |
0.326 |
|
| 2009 |
Kohut E, Hajdu M, Gergely P, Gopcsa L, Kilián K, Pálóczi K, Kopper L, Sebestyén A. Expression of TGFbeta1 and its signaling components by peripheral lymphocytes in systemic lupus erythematosus. Pathology Oncology Research : Por. 15: 251-6. PMID 19020994 DOI: 10.1007/S12253-008-9119-8 |
0.323 |
|
| 2008 |
Stelkovics E, Korom I, Marczinovits I, Molnar J, Rasky K, Raso E, Ficsor L, Molnar B, Kopper L, Krenacs T. Collagen XVII/BP180 protein expression in squamous cell carcinoma of the skin detected with novel monoclonal antibodies in archived tissues using tissue microarrays and digital microscopy. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 16: 433-41. PMID 18633319 DOI: 10.1097/Pai.0B013E318162F8Aa |
0.313 |
|
| 2008 |
Barna G, Reiniger L, Tátrai P, Kopper L, Matolcsy A. The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL. Hematological Oncology. 26: 167-70. PMID 18381689 DOI: 10.1002/Hon.855 |
0.577 |
|
| 2008 |
Nagy K, Barti-Juhász H, Árvai K, Schwab R, Peták I, Kopper L. A TRAIL (TNF-related-apoptosis inducing ligand) és bortezomib a vastagbélrák személyreszabott kezelésében Zeitschrift FüR Gastroenterologie. 46. DOI: 10.1055/S-2008-1079673 |
0.325 |
|
| 2007 |
Schwab R, Micsik T, Szokolóczi O, Schafer E, Tihanyi B, Tihanyi T, Kupcsulik P, Diófalvi K, Mersich T, Besznyak I, Zarand A, Mihalik R, Sarkadi B, Kéri G, Pap A, ... ... Kopper L, et al. Functional evaluation of multidrug resistance transporter activity in surgical samples of solid tumors. Assay and Drug Development Technologies. 5: 541-50. PMID 17767422 DOI: 10.1089/Adt.2007.067 |
0.376 |
|
| 2007 |
Sebestyén A, Hajdu M, Kis L, Barna G, Kopper L. Smad4-independent, PP2A-dependent apoptotic effect of exogenous transforming growth factor beta 1 in lymphoma cells. Experimental Cell Research. 313: 3167-74. PMID 17643425 DOI: 10.1016/J.Yexcr.2007.05.028 |
0.719 |
|
| 2007 |
Papay J, Krenacs T, Moldvay J, Stelkovics E, Furak J, Molnar B, Kopper L. Immunophenotypic profiling of nonsmall cell lung cancer progression using the tissue microarray approach. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 15: 19-30. PMID 17536303 DOI: 10.1097/01.Pai.0000213143.32030.F5 |
0.417 |
|
| 2007 |
Végso G, Sebestyén A, Paku S, Barna G, Hajdu M, Tóth M, Járay J, Kopper L. Antiproliferative and apoptotic effects of mycophenolic acid in human B-cell non-Hodgkin lymphomas. Leukemia Research. 31: 1003-8. PMID 17320952 DOI: 10.1016/J.Leukres.2006.12.019 |
0.691 |
|
| 2007 |
Hajdu M, Sebestyén A, Barna G, Reiniger L, Jánosi J, Sréter L, Várkonyi J, Demeter J, Kopper L. Activity of the notch-signalling pathway in circulating human chronic lymphocytic leukaemia cells. Scandinavian Journal of Immunology. 65: 271-5. PMID 17309782 DOI: 10.1111/J.1365-3083.2006.01897.X |
0.648 |
|
| 2007 |
Sebestyén A, Hajdu M, Barna G, Kopper L. 381 POSTER Rapamycin potentiates the apoptotic effect of TGFb in lymphoma cells European Journal of Cancer Supplements. 5: 79. DOI: 10.1016/S1359-6349(07)70399-3 |
0.657 |
|
| 2006 |
Nagy K, Székely-Szüts K, Izeradjene K, Douglas L, Tillman M, Barti-Juhász H, Dominici M, Spano C, Luca Cervo G, Conte P, Houghton JA, Mihalik R, Kopper L, Peták I. Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria. Pathology Oncology Research : Por. 12: 133-42. PMID 16998592 DOI: 10.1007/Bf02893359 |
0.651 |
|
| 2006 |
Reiniger L, Bödör C, Bognár A, Balogh Z, Csomor J, Szepesi A, Kopper L, Matolcsy A. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation. Leukemia. 20: 1089-95. PMID 16541139 DOI: 10.1038/Sj.Leu.2404183 |
0.351 |
|
| 2006 |
Petak I, Houghton J, Kopper L. Molecular Targeting of Cell Death Signal Transduction Pathways in Cancer Current Signal Transduction Therapy. 1: 113-131. DOI: 10.2174/157436206775269217 |
0.341 |
|
| 2005 |
Barna G, Sebestyén A, Weischede S, Peták I, Mihalik R, Formelli F, Kopper L. Different ways to induce apoptosis by fenretinide and all-trans-retinoic acid in human B lymphoma cells. Anticancer Research. 25: 4179-85. PMID 16309214 |
0.673 |
|
| 2005 |
Nagy K, Petak I, Imre G, Barna G, Gezane-Csorba M, Sebestyen A, Houghton JA, Mihalik R, Kopper L. Proteasome inhibitors abolish cell death downstream of caspase activation during anti-microtubule drug-induced apoptosis in leukemia cells. Anticancer Research. 25: 3321-6. PMID 16101145 |
0.717 |
|
| 2005 |
Bognár A, Csernus B, Bödör C, Reiniger L, Szepesi A, Tóth E, Kopper L, Matolcsy A. Clonal selection in the bone marrow involvement of follicular lymphoma. Leukemia. 19: 1656-62. PMID 15973453 DOI: 10.1038/Sj.Leu.2403844 |
0.359 |
|
| 2005 |
Sebestyén A, Barna G, Nagy K, Jánosi J, Paku S, Kohut E, Berczi L, Mihalik R, Kopper L. Smad signal and TGFbeta induced apoptosis in human lymphoma cells. Cytokine. 30: 228-35. PMID 15927846 DOI: 10.1016/J.Cyto.2005.01.013 |
0.744 |
|
| 2005 |
Bödör C, Bognár A, Reiniger L, Szepesi A, Tóth E, Kopper L, Matolcsy A. Aberrant somatic hypermutation and expression of activation-induced cytidine deaminase mRNA in mediastinal large B-cell lymphoma. British Journal of Haematology. 129: 373-6. PMID 15842661 DOI: 10.1111/J.1365-2141.2005.05454.X |
0.346 |
|
| 2005 |
Mihalik R, Imre G, Petak I, Szende B, Kopper L. Cathepsin B-independent abrogation of cell death by CA-074-OMe upstream of lysosomal breakdown. Cell Death and Differentiation. 11: 1357-60. PMID 15297886 DOI: 10.1038/Sj.Cdd.4401493 |
0.336 |
|
| 2004 |
Jánosi J, Sebestyén A, Bocsi J, Barna G, Nagy K, Vályi-Nagy I, Kopper L. [Mevastatin induced apoptosis in U266 human myeloma cell line]. Magyar Onkologia. 48: 333-7. PMID 15655579 |
0.741 |
|
| 2004 |
Csernus B, Timár B, Fülöp Z, Bognár A, Szepesi A, László T, Jáksó P, Warnke R, Kopper L, Matolcsy A. Mutational analysis of IgVH and BCL-6 genes suggests thymic B-cells origin of mediastinal (thymic) B-cell lymphoma. Leukemia & Lymphoma. 45: 2105-10. PMID 15370257 DOI: 10.1080/1042819042000219467 |
0.392 |
|
| 2004 |
Jánosi J, Sebestyén A, Bocsi J, Barna G, Nagy K, Vályi-Nagy I, Kopper L. Mevastatin-induced apoptosis and growth suppression in U266 myeloma cells. Anticancer Research. 24: 1817-22. PMID 15274361 |
0.74 |
|
| 2004 |
Szende B, Farid P, Végso G, Perner F, Kopper L. Apoptosis and P53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism. Pathology Oncology Research : Por. 10: 98-103. PMID 15188026 DOI: 10.1007/Bf02893463 |
0.417 |
|
| 2004 |
Paku S, Nagy P, Kopper L, Thorgeirsson SS. 2-acetylaminofluorene dose-dependent differentiation of rat oval cells into hepatocytes: confocal and electron microscopic studies. Hepatology (Baltimore, Md.). 39: 1353-61. PMID 15122764 DOI: 10.1002/Hep.20178 |
0.346 |
|
| 2003 |
Paku S, Tóvári J, Lörincz Z, Timár F, Döme B, Kopper L, Raz A, Tímár J. Adhesion dynamics and cytoskeletal structure of gliding human fibrosarcoma cells: a hypothetical model of cell migration. Experimental Cell Research. 290: 246-53. PMID 14567984 DOI: 10.1016/S0014-4827(03)00334-3 |
0.363 |
|
| 2003 |
Petak I, Danam RP, Tillman DM, Vernes R, Howell SR, Berczi L, Kopper L, Brent TP, Houghton JA. Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma. Cell Death and Differentiation. 10: 211-7. PMID 12700649 DOI: 10.1038/Sj.Cdd.4401132 |
0.358 |
|
| 2003 |
Krenacs L, Smyth MJ, Bagdi E, Krenacs T, Kopper L, Rudiger T, Zettl A, Muller-Hermelink HK, Jaffe ES, Raffeld M. The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity. Blood. 101: 3590-3. PMID 12506019 DOI: 10.1182/Blood-2002-09-2908 |
0.354 |
|
| 2002 |
Barna G, Sebestyén A, Chinopoulos CC, Nagy K, Mihalik R, Paku S, Kopper L. TGF beta 1 kills lymphoma cells using mitochondrial apoptotic pathway with the help of caspase-8. Anticancer Research. 22: 3867-72. PMID 12553006 |
0.733 |
|
| 2002 |
Tímár J, Lapis K, Dudás J, Sebestyén A, Kopper L, Kovalszky I. Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. Seminars in Cancer Biology. 12: 173-86. PMID 12083848 DOI: 10.1016/S1044-579X(02)00021-4 |
0.36 |
|
| 2002 |
Tímár J, Csuka O, Orosz Z, Jeney A, Kopper L. Molecular pathology of tumor metastasis. I. Predictive pathology. Pathology Oncology Research : Por. 7: 217-30. PMID 11692150 DOI: 10.1007/Bf03032353 |
0.302 |
|
| 2001 |
Tótth A, Sebestyén A, Barna G, Nagy K, Göndör A, Bocsi J, Mihalik R, Peták I, Houghton J, Kopper L. TGF beta 1 induces caspase-dependent but death-receptor independent apoptosis in lymphoid cells. Anticancer Research. 21: 1207-12. PMID 11396165 |
0.739 |
|
| 2001 |
Sebestyen A, Barna G, Gondor A, Nagy K, Weishede S, Bauer P, Kopper L. The apoptotic effect of TGF-beta in human lymphoma cells European Journal of Cancer. 37: S123. DOI: 10.1016/S0959-8049(01)80941-2 |
0.654 |
|
| 2000 |
Sebestyén A, Tótth A, Mihalik R, Szakács O, Paku S, Kopper L. Syndecan-1-dependent homotypic cell adhesion in HT58 lymphoma cells. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 21: 349-57. PMID 11006575 DOI: 10.1159/000030140 |
0.402 |
|
| 2000 |
Kopper L, Sebestyén A. Syndecans and the lymphoid system. Leukemia & Lymphoma. 38: 271-81. PMID 10830734 DOI: 10.3109/10428190009087018 |
0.415 |
|
| 1999 |
Mihalik R, Bauer P, Peták I, Krajcsi P, Marton A, Kun E, Kopper L. Interaction of cytocidal drugs and the inhibition of caspase-3 by 3-nitrosobenzamide. International Journal of Cancer. Journal International Du Cancer. 82: 875-9. PMID 10446456 DOI: 10.1002/(Sici)1097-0215(19990909)82:6<875::Aid-Ijc17>3.0.Co;2-T |
0.437 |
|
| 1999 |
Sebestyén A, Berczi L, Mihalik R, Paku S, Matolcsy A, Kopper L. Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas. British Journal of Haematology. 104: 412-9. PMID 10050727 DOI: 10.1046/J.1365-2141.1999.01211.X |
0.383 |
|
| 1999 |
Mihalik R, Sebestyén A, Barna G, Bauer P, Kopper L. Death receptors in etoposide treated lymphoma cells European Journal of Cancer. 35: S104. DOI: 10.1016/S0959-8049(99)80798-9 |
0.649 |
|
| 1998 |
Kovalszky I, Dudás J, Oláh-Nagy J, Pogány G, Töváry J, Timár J, Kopper L, Jeney A, Iozzo RV. Inhibition of DNA topoisomerase I activity by heparan sulfate and modulation by basic fibroblast growth factor. Molecular and Cellular Biochemistry. 183: 11-23. PMID 9655174 DOI: 10.1023/A:1006898920637 |
0.308 |
|
| 1998 |
Sebestyén A, Kovalszky I, Mihalik R, Gallai M, Bocsi J, László E, Benedek S, Sréter L, Kopper L. Expression of syndecan-1 in human B cell chronic lymphocytic leukaemia. European Journal of Cancer (Oxford, England : 1990). 33: 2273-7. PMID 9470818 DOI: 10.1016/S0959-8049(97)00248-7 |
0.404 |
|
| 1997 |
Mihalik R, Uher F, Peták, Sebestyén A, Kopper L. Regulation of Differentiation, Proliferation and Drug-Induced Apoptosis in HT58 Lymphoma Cells. Pathology Oncology Research : Por. 3: 100-105. PMID 11173634 DOI: 10.1007/Bf02907802 |
0.308 |
|
| 1996 |
Tótth Á, Schnur J, Ladányi A, Kopper L. Intracerebral Human Lymphoma - An Experimental Model. Pathology Oncology Research : Por. 2: 174-176. PMID 11173602 DOI: 10.1007/Bf02903522 |
0.4 |
|
| 1996 |
Mihalik R, Uher F, Pocsik É, Berczi L, Benczur M, Kopper L. Detection of Drug-induced Apoptosis by Flow Cytometry after Alkaline Extraction of Ethanol Fixed Cells. Pathology Oncology Research : Por. 2: 78-83. PMID 11173591 DOI: 10.1007/Bf02893956 |
0.406 |
|
| 1996 |
Mihalik R, Kopper L, Benczúr M. Modulation of drug-induced apoptosis in a human B-lymphoma cell line (HT58). Immunology Letters. 48: 17-21. PMID 8847085 DOI: 10.1016/0165-2478(95)02434-4 |
0.474 |
|
| 1996 |
Mihalik R, Farkas G, Kopper L, Benczúr M, Faragó A. Possible involvement of protein kinase C-epsilon in phorbol ester-induced growth inhibition of human lymphoblastic cells. The International Journal of Biochemistry & Cell Biology. 28: 925-33. PMID 8811841 DOI: 10.1016/1357-2725(96)00020-9 |
0.418 |
|
| 1996 |
Csáki C, Ferencz T, Sipos G, Kopper L, Schuler D, Borsi JD. Diffuse plasmacytosis in a child with brainstem glioma following multiagent chemotherapy and intensive growth factor support. Medical and Pediatric Oncology. 26: 367-71. PMID 8614371 DOI: 10.1002/(Sici)1096-911X(199605)26:5<367::Aid-Mpo10>3.0.Co;2-A |
0.317 |
|
| 1995 |
Timár J, Jeney A, Kovalszky, Kopper L. Role of Proteoglycans in Tumor Progression. Pathology Oncology Research : Por. 1: 85-93. PMID 11173574 DOI: 10.1007/Bf02893590 |
0.341 |
|
| 1995 |
Tímár J, Diczházi C, Bartha I, Pogány G, Paku S, Rásó E, Tóvári J, Ladányi A, Lapis K, Kopper L. Modulation of heparan-sulphate/chondroitin-sulphate ratio by glycosaminoglycan biosynthesis inhibitors affects liver metastatic potential of tumor cells. International Journal of Cancer. 62: 755-61. PMID 7558426 DOI: 10.1002/Ijc.2910620618 |
0.366 |
|
| 1991 |
Nagy P, Török N, Ladånyi A, Kopper L. Expression of transforming growth factor-beta 1 in human non-Hodgkin's lymphoma xenografts. Journal of the National Cancer Institute. 83: 1174-5. PMID 1886149 DOI: 10.1093/Jnci/83.16.1174 |
0.33 |
|
| 1990 |
Kopper L, Bankfalvi A, Mihalik R, Glant TT, Timar J. Proteoglycan-targeted antibodies as markers on non-Hodgkin lymphoma xenografts Cancer Immunology, Immunotherapy. 32: 137-142. PMID 2289206 DOI: 10.1007/Bf01754211 |
0.334 |
|
| 1990 |
Timár J, Kovalszky I, Bánkfalvi A, Kopper L. Ultrastructural localization and internalization of proteoglycan epitopes in a human non-Hodgkin (B) lymphoma. Histochemistry. 94: 419-25. PMID 1699917 DOI: 10.1007/Bf00266450 |
0.376 |
|
| 1987 |
Rajnay J, Kopper L, Lapis K. Chemotherapeutic response of squamous cell carcinoma xenografts (subcutaneous and subrenal capsule assay). Oncology. 44: 307-11. PMID 3670798 DOI: 10.1159/000226500 |
0.323 |
|
| 1987 |
Timár J, Móczar E, Timár F, Pál K, Kopper L, Lapis K, Jeney A. Comparative study on Lewis lung tumor lines with 'low' and 'high' metastatic capacity. II. Cytochemical and biochemical evidence for differences in glycosaminoglycans. Clinical & Experimental Metastasis. 5: 79-87. PMID 3103961 DOI: 10.1007/Bf00116628 |
0.362 |
|
| 1987 |
Timar J, Kopper L, Pogany G, Jeney A, Lapis K. Effect of an anti-GAG agent KL-103 on tumour cell membranes and microinvasiveness European Journal of Cancer and Clinical Oncology. 23: 1805. DOI: 10.1016/0277-5379(87)90741-3 |
0.32 |
|
| 1987 |
Lapis K, Timár J, Pál K, Kopper L, Jeney A. Phenotype of metastatic cells as target for anti-metastatic interventions European Journal of Cancer and Clinical Oncology. 23: 1773. DOI: 10.1016/0277-5379(87)90627-4 |
0.317 |
|
| 1985 |
Lapis P, Kopper L, Bodrogi I, Sugár J, Lapis K, Eckhardt S. Characteristics and chemotherapeutic sensitivity of a human testicular cancer grown in artificially immunosuppressed mice. Oncology. 42: 112-8. PMID 2581199 DOI: 10.1159/000226012 |
0.361 |
|
| 1985 |
Lapis K, Timár J, Timár F, Pál K, Móczár E, Kopper L, Jeney A. Cell membrane alterations in highly metastatic tumour cells European Journal of Cancer and Clinical Oncology. 21: 1398. DOI: 10.1016/0277-5379(85)90417-1 |
0.365 |
|
| 1984 |
Kopper L, Magyarosy E, Nagy P, Lapis K, Számel I, Eckhardt S, Csata S, Wabrosch G, Répássy D. Renal cell carcinoma--xenotransplantation into immuno-suppressed mice. Oncology. 41: 19-24. PMID 6700931 DOI: 10.1159/000225784 |
0.322 |
|
| 1984 |
Kopper L, Magyarosy E, Jeney A, Lapis K, Szabolcs A, Otvös L. Potentiation of the antitumor action of 5-fluorouracil with 5-ethyl-2'-deoxyuridine in human colorectal tumor xenografts. Oncology. 41: 155-8. PMID 6328393 DOI: 10.1159/000225813 |
0.306 |
|
| 1983 |
Timár J, Kopper L, Pál K, Lapis K. Transmission and scanning-electronmicroscopy of experimental liver metastases derived from intrasplenically growing primary tumor. Pathology, Research and Practice. 177: 47-59. PMID 6622294 DOI: 10.1016/S0344-0338(83)80043-0 |
0.359 |
|
| 1981 |
Kopper L, Van Hanh T, Hegedüs C, Lapis K. Growth of human colorectal tumor xenografts in immunosuppressed mice reconstituted with normal cells. Experimental Cell Biology. 49: 141-7. PMID 6972884 DOI: 10.1159/000163816 |
0.308 |
|
| 1978 |
Kopper L, Jeney A, Lapis K, Török M. Studies of the growth of an ascitic tumour. II. A system to study the tumour-age dependent effect of antitumour agents. European Journal of Cancer. 14: 75-82. PMID 624305 DOI: 10.1016/0014-2964(78)90140-8 |
0.301 |
|
| 1978 |
Kopper L, Jeney A, Takács J, Benedeczky I, Dzurillay E, Lapis K. Studies of the growth of an ascitic tumour. I. Cellular and subcellular changes during the tumour growth. European Journal of Cancer. 14: 59-73. PMID 624304 DOI: 10.1016/0014-2964(78)90139-1 |
0.343 |
|
| 1976 |
Kopper L, Jeney A, Ferencz G, Lapis K, Szende B. Studies on in vitro carcinogenesis. I. Autoradiographic and biochemical study on the incorporation of labelled methylcholantrene into mouse embryonic cells. Zeitschrift Fur Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology. 85: 117-24. PMID 130740 DOI: 10.1007/Bf00304944 |
0.312 |
|
| Show low-probability matches. |